Abstract:Purpose The purpose of this study was to assess the accuracy of susceptibility-weighted imaging (SWI), compared with T2*-weighted gradient echo (GRE) imaging in assessing cerebral cavernous malformations. Materials and methods We retrospectively evaluated 21 patients with a familial form of cavernous malformation. Magnetic resonance (MR) protocol included non-enhanced and contrast-enhanced fast-spin echo (FSE) T1-weighted sequences, FSE T2-weighted sequences, fluid-attenuated inversion-recovery (FLAIR), GRE T2*-weighted and SWI sequences. Images were reviewed in consensus by two expert neuroradiologists to assess the location, number, size and conspicuity of the lesions on T2*-weighted GRE and SWI sequences. Statistical differences in the number, size and conspicuity of the lesions seen on the SWI images and the T2*-weighted GRE images were assessed with the nonparametric Wilcoxon signed rank test. Results The number of cavernous malformations was significantly higher ( p < .001) on the SWI images ( n = 152) than on T2*-weighted GRE images ( n = 56). Lesion size was significantly higher ( p < .001) on SWI images (mean: 0.4 cm, SD ± 0.55) than on T2*-weighted GRE sequences (mean: 0.2 cm, SD ± 0.51) and the differences were statistically significant ( p < .001). Lesion conspicuity was significant higher ( p < .001) on SWI than on T2*-weighted GRE images. In one patient who underwent a 2-month follow-up for the onset of neurologic symptoms related to cerebral hemorrhage, a cerebral hematoma was identified at the site of a cerebral cavernous malformation that was demonstrated only on the SWI images in the previous MR examination. Conclusions The SWI sequence, being more sensitive to substances which distort the local magnetic field than the GRE T2*W sequence, showed a higher sensitivity in identifying cerebral cavernous malformations. Thus, routine clinical neuroimaging protocol should contain SWI sequences to evaluate patients with (or suspected) cerebral cavernous malformations.

The Application of MR Susceptibility Weighted Imaging in Cranial Vascular Malformation

Enhancement of Venous Vasculature in Susceptibility Weighted Images of the Brain Using Multi-Scale Vessel Enhancement Filtering

Reduction of artifacts in susceptibility-weighted MR venography of the brain.

Application of SWI in Diagnosis and Differential Diagnosis of Hemangioma in Skeletal Muscle

Application of Susceptibility Weighted Imaging in Pediatric Neurologic Disorders

Susceptibility-weighted Magnetic Resonance Imaging in Brain Masses:Initial Experience

Value of MR susceptibility weighted angiography (SWAN)imaging in the diagnosis of brain diseases in children

Application of susceptibility-weighted magnetic resonance imaging in intracranial neoplasm

Application of Susceptibility Weighted Imaging(SWI) in Neonatal Intracranial Hemorrhage

Evaluation of cerebral haemorrhage SWI in by at 3.0 T MRI

Multi‐echo Acquisition of MR Angiography and Venography of the Brain at 3 Tesla

Applications of Susceptibility Weighted Imaging in Central Nervous System

A Comparison Study of Single-Echo Susceptibility Weighted Imaging and Combined Multi-Echo Susceptibility Weighted Imaging in Visualizing Asymmetric Medullary Veins in Stroke Patients.

Clinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a review

Value of Multiple Sequences at 3.0T Magnetic Resonance Imaging for Diagnosis of Cerebral Microbleeds

Clinical Application of Susceptibility Weighted Imaging in Brain Tumors

Susceptibility weighted imaging: Clinical applications and future directions

Post-processing Algorithm of Susceptibility Weighted Imaging and Its Clinical Application

Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form

Mr Venography of the Brain with Enhanced Vessel Contrast Using Image-Domain High-Pass Filtering of the Susceptibility Phase Shift